Literature DB >> 16460672

Identification of a novel CoA synthase isoform, which is primarily expressed in the brain.

Ivan Nemazanyy1, Ganna Panasyuk, Oksana Breus, Alexander Zhyvoloup, Valeriy Filonenko, Ivan T Gout.   

Abstract

CoA and its derivatives Acetyl-CoA and Acyl-CoA are important players in cellular metabolism and signal transduction. CoA synthase is a bifunctional enzyme which mediates the final stages of CoA biosynthesis. In previous studies, we have reported molecular cloning, biochemical characterization, and subcellular localization of CoA synthase (CoASy). Here, we describe the existence of a novel CoA synthase isoform, which is the product of alternative splicing and possesses a 29aa extension at the N-terminus. We termed it CoASy beta and originally identified CoA synthase, CoASy alpha. The transcript specific for CoASy beta was identified by electronic screening and by RT-PCR analysis of various rat tissues. The existence of this novel isoform was further confirmed by immunoblot analysis with antibodies directed to the N-terminal peptide of CoASy beta. In contrast to CoASy alpha, which shows ubiquitous expression, CoASy beta is primarily expressed in the brain. Using confocal microscopy, we demonstrated that both isoforms are localized on mitochondria. The N-terminal extension does not affect the activity of CoA synthase, but possesses a proline-rich sequence which can bring the enzyme into complexes with signalling proteins containing SH3 or WW domains. The role of this novel isoform in CoA biosynthesis, especially in the brain, requires further elucidation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460672     DOI: 10.1016/j.bbrc.2006.01.051

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.

Authors:  C E Arber; A Li; H Houlden; S Wray
Journal:  Neuropathol Appl Neurobiol       Date:  2015-06-02       Impact factor: 8.090

2.  Investigation of Mitochondrial Related Variants in a Cerebral Small Vessel Disease Cohort.

Authors:  P J Dunn; N R Harvey; N Maksemous; R A Smith; H G Sutherland; L M Haupt; L R Griffiths
Journal:  Mol Neurobiol       Date:  2022-06-14       Impact factor: 5.682

3.  Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation.

Authors:  Sabrina Dusi; Lorella Valletta; Tobias B Haack; Yugo Tsuchiya; Paola Venco; Sebastiano Pasqualato; Paola Goffrini; Marco Tigano; Nikita Demchenko; Thomas Wieland; Thomas Schwarzmayr; Tim M Strom; Federica Invernizzi; Barbara Garavaglia; Allison Gregory; Lynn Sanford; Jeffrey Hamada; Conceição Bettencourt; Henry Houlden; Luisa Chiapparini; Giovanna Zorzi; Manju A Kurian; Nardo Nardocci; Holger Prokisch; Susan Hayflick; Ivan Gout; Valeria Tiranti
Journal:  Am J Hum Genet       Date:  2013-12-19       Impact factor: 11.025

4.  Mitochondrial dysfunction and defects in lipid homeostasis as therapeutic targets in neurodegeneration with brain iron accumulation.

Authors:  Kerri J Kinghorn; Jorge Iván Castillo-Quan
Journal:  Rare Dis       Date:  2016-01-25

5.  Acetyl-4'-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency.

Authors:  Ivano Di Meo; Cristina Colombelli; Balaji Srinivasan; Marianne de Villiers; Jeffrey Hamada; Suh Y Jeong; Rachel Fox; Randall L Woltjer; Pieter G Tepper; Liza L Lahaye; Emanuela Rizzetto; Clara H Harrs; Theo de Boer; Marianne van der Zwaag; Branko Jenko; Alen Čusak; Jerca Pahor; Gregor Kosec; Nicola A Grzeschik; Susan J Hayflick; Valeria Tiranti; Ody C M Sibon
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

Review 6.  Defective lipid metabolism in neurodegeneration with brain iron accumulation (NBIA) syndromes: not only a matter of iron.

Authors:  Cristina Colombelli; Manar Aoun; Valeria Tiranti
Journal:  J Inherit Metab Dis       Date:  2014-10-10       Impact factor: 4.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.